31 Stocks Moving In Monday's Mid-Day Session

Gainers

• Ossen Innovation Co., Ltd. OSN shares surged 20.6 percent to $2.8338.
• Eldorado Resorts, Inc. ERI shares climbed 15.7 percent to $41.30 after the company announced plans to buy Tropicana Entertainment for $1.85 billion in cash. MGM Resorts International MGM reported the sale of Grand Victoria Casino in Elgin, Illinois to Eldorado Resorts for $327.5 million in cash.
• Turtle Beach Corporation HEAR shares rose 13.3 percent to $4.43.
• Carvana Co. CVNA shares rose 11 percent to $25.98.
• BlueLinx Holdings Inc. BXC shares gained 10.8 percent to $39.52. BlueLinx disclosed that it has completed its announced acquisition of Cedar Creek.
• Bovie Medical Corporation BVX climbed 9.6 percent to $3.48.
• Viveve Medical, Inc. VIVE shares rose 9.3 percent to $3.29.
• Aptose Biosciences Inc. APTO climbed 8.6 percent to $ 3.5717. Aptose announced the presentation of new preclinical data on CG’806 Pan-FLT3/ Pan-BTK inhibitor at the 2018 AACR Annual Meeting.
• Alkermes plc ALKS gained 8.4 percent to $46.09 after the company reported the FDA acceptance for review of the NDA for ALKS 5461 for the adjunctive treatment of major depressive disorder.
• Partner Communications Company Ltd. PTNR shares rose 8.2 percent to $4.51 after the company reported a collaboration deal with Amazon Video in Israel.
• REGENXBIO Inc. RGNX shares rose 7.7 percent to $37.25.
• Helios and Matheson Analytics Inc. HMNY rose 6.9 percent to $3.4299 after climbing 6.29 percent on Friday.
• National Beverage Corp. FIZZ gained 4.1 percent to $93.14. Imperial Capital initiated coverage on National Beverage with an Outperform rating.
• C.H. Robinson Worldwide, Inc. CHRW rose 4 percent to $98.02. UBS upgraded C.H. Robinson from Neutral to Buy.

Check out these big penny stock gainers and losers

Losers

• Celldex Therapeutics, Inc. CLDX shares dipped 60.4 percent to $0.8521 after the company disclosed that its METRIC study in metastatic triple-negative breast cancer did not meet primary endpoint.
• Acacia Communications, Inc. ACIA shares tumbled 34 percent to $26.43. Optical stocks were trading under notable selling pressure Monday morning in reaction to the U.S. government's move to ban American companies from selling their equipment to China's ZTE Corp. The company said in a 10-K filing dated Feb. 22 it generates most of its revenue from a limited number of customers. Among its biggest customers is ZTE, which accounted for 30 percent of its entire revenue in 2017.
• Apricus Biosciences, Inc. APRI fell 31.3 percent to $0.2884. The urology and rheumatology focused biopharmaceutical company said the FDA recommended the company reformulates its Vitaros therapy. Specifically, the FDA is recommending the company "develop a new Vitaros formulation that reduces the concentration of DDAIP.HCl from 2.5% to 0.5% in order to address the tumor promotion and partner transference safety concerns."
• Novume Solutions, Inc. NVMM fell 23.6 percent to $2.5503.
• Nektar Therapeutics NKTR shares tumbled 17.8 percent to $82.62. Nektar Therapeutics presented new preclinical data for its immuno-oncology programs at the AACR.
• Oclaro, Inc. OCLR declined 17.5 percent to $7.7695. Optical stocks were trading under notable selling pressure Monday morning in reaction to the U.S. government's move to ban American companies from selling their equipment to China's ZTE Corp. Oclaro shares fell as ZTE accounted for 18 percent of its 2017 revenue.
• CYANOTECH CORP CYAN dropped 16 percent to $4.24.
• NewLink Genetics Corporation NLNK fell 13.9 percent to $3.850 after the company reported initial Phase 1 data with indoximod plus radiation and chemotherapy for pediatric patients with diffuse intrinsic pontine glioma at the American Association for Cancer Research (AACR) 2018 Annual Meeting.
• Blueprint Medicines Corporation BPMC dropped 13.6 percent to $85.57 after the company disclosed proof-of-concept data from the ongoing Phase 1 ARROW clinical trial of BLU-667 in patients with RET-altered solid tumors.
• VirnetX Holding Corp VHC shares fell 13.3 percent to $3.25.
• Cerecor Inc. CERC declined 13.2 percent to $3.21.
• Inphi Corporation IPHI dropped 11.6 percent to $28.96. Inphi is expected to release Q1 results on April 24.
• Fabrinet FN shares declined 11.4 percent to $ 29.65.
• Zafgen, Inc. ZFGN shares fell 10.4 percent to $6.89.
• Clovis Oncology, Inc. CLVS dropped 10 percent to $54.57 after the company disclosed proposed offerings of convertible senior notes and common stock.
• National Oilwell Varco, Inc. NOV shares fell 6.1 percent to $38.42 after the company issued weak sales forecast for the first quarter.
• WPP plc WPP fell 5.5 percent to $79.90 after the company disclosed that Sir Martin Sorrell has stepped down as CEO of the company.